ArticleCancer immunology, immunotherapy : CII2023

The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer.

Ziyun Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.